The Patent Finder

Modalis Therapeutics Corporation

Also on record
Records under this name other than the patents Modalis Therapeutics Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 2 of 2 · Back to Modalis Therapeutics Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,530,396Modified CAS9 Protein, and Use Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,439,692Method of Treating Diseases Associated with MYD88 Pathways Using CRISPR-Gndm System
Lapsed on the fee record
Ended Sep 13, 2026 · High confidence
Lapsed on the fee recordEnded Sep 13, 2026High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited